EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity

Benjamin F Gruenbaum iD, Kiran S Merchant iD, Alexander Zlotnik, Matthew Boyko iD

Nutrients · 22.12.2024 · 16 (24) · 4405

DOI: 10.3390/nu16244405 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 22.12.2024. Verfasst von Benjamin F Gruenbaum und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL 32224, USA. Hauptthemen laut MEDLINE: Gastrointestinal Microbiome, Glutamic Acid, Brain-Gut Axis, Brain. Die Arbeit wurde bisher 36-mal zitiert (Crossref) und nennt 97 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The gut–brain axis plays an integral role in maintaining overall health, with growing evidence suggesting its impact on the development of various neuropsychiatric disorders, including depression. This review explores the complex relationship between gut microbiota and glutamate (Glu) regulation, highlighting its effect on brain health, particularly in the context of depression following certain neurological insults. We discuss how microbial populations can either facilitate or limit Glu uptake, influencing its bioavailability and predisposing to neuroinflammation and neurotoxicity. Additionally, we examine the role of gut metabolites and their influence on the blood–brain barrier and neurotransmitter systems involved in mood regulation. The therapeutic potential of microbiome-targeted interventions, such as fecal microbiota transplantation, is also highlighted. While much research has explored the role of Glu in major depressive disorders and other neurological diseases, the contribution of gut microbiota in post-neurological depression remains underexplored. Future research should focus on explaining the mechanisms linking the gut microbiota to neuropsychiatric outcomes, particularly in conditions such as post-stroke depression, post-traumatic brain-injury depression, and epilepsy-associated depression. Systematic reviews and human clinical studies are needed to establish causal relationships and assess the efficacy of microbiome-targeted therapies in improving the neuropsychiatric sequalae after neurological insults.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Gastrointestinal MicrobiomeGlutamic AcidBrain-Gut AxisBrainHumansAnimalsFecal Microbiota TransplantationBlood-Brain BarrierNeurotoxicity SyndromesDepression

Stichwörter der Autor:innen

blood–brain barrierdepressionepilepsyglutamategut microbiomeneurodegenerationstroketraumatic brain injury

Substanzen

Glutamic Acid

Autor:innen und Institutionen

  • Department of Anesthesiology and Perioperative Medicine, Mayo Clinic, Jacksonville, FL 32224, USA.
  • Department of Anesthesiology and Critical Care, Soroka University Medical Center, Ben-Gurion University of the Negev, Beer-Sheva 84101, Israel.

ORCID-Profile: Benjamin F Gruenbaum, Kiran S Merchant, Matthew Boyko

Zitieren

APA

Gruenbaum, B. F., Merchant, K. S., Zlotnik, A., & Boyko, M. (2024). Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity. Nutrients, 16(24), 4405. https://doi.org/10.3390/nu16244405

Vancouver

Gruenbaum BF, Merchant KS, Zlotnik A, Boyko M. Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity. Nutrients. 2024;16(24):4405. doi:10.3390/nu16244405

BibTeX
@article{Gruenbaum2024,
  author = {Gruenbaum, Benjamin F and Merchant, Kiran S and Zlotnik, Alexander and Boyko, Matthew},
  title = {Gut Microbiome Modulation of Glutamate Dynamics: Implications for Brain Health and Neurotoxicity},
  journal = {Nutrients},
  year = {2024},
  volume = {16},
  number = {24},
  pages = {4405},
  doi = {10.3390/nu16244405}
}
Kostenlos starten →